Trials / Completed
CompletedNCT01024803
Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients: A Prospective Multicenter Clinical Study Based on Randomized Intra-individual Implant Activation in Patients With Degenerative Retinal Diseases
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Retina Implant AG · Industry
- Sex
- All
- Age
- 18 Years – 78 Years
- Healthy volunteers
- Not accepted
Summary
Patients suffering from hereditary retinal degeneration receive a retinal implant to restore sight. Subretinal implant "ON" results in significant visual acuity improvement, when compared to "OFF" condition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Device name: "Retina Implant model Alpha". Surgical implantation of medical device into eye | Surgical implantation of medical device named "Retina Implant" into eye to restore vision partially. Randomized intra-individual implant activation in patient under test conditions such as: FrACT, BaLM, BaGA, maze, ADL. |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2017-04-01
- Completion
- 2018-04-01
- First posted
- 2009-12-03
- Last updated
- 2018-09-05
Locations
6 sites across 3 countries: Germany, Hungary, United Kingdom
Source: ClinicalTrials.gov record NCT01024803. Inclusion in this directory is not an endorsement.